Oncorus Performance
The company owns a Beta (Systematic Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Oncorus are completely uncorrelated.
Risk-Adjusted Performance
Weak
Weak | Strong |
Over the last 90 days, Oncorus generated negative risk-adjusted returns and added little value for investors with long positions. The result matters because weak risk-adjusted return can persist even when isolated price moves briefly look constructive. Even with relatively invariable fundamental indicators, Oncorus is not utilizing all of its potential. The latest price agitation may contribute to short-term losses for retail investors. Learn More
Oncorus |
Oncorus Relative Risk vs. Return Landscape
If you had invested $-100.00 in Oncorus on December 11, 2025 and sold it today you would have earned a total of $ 100.00 from holding Oncorus or generated -100.0% return on investment over 90 days. Oncorus does not currently generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over a 90-day horizon. In different words, 0% of stocks are less volatile than Oncorus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Oncorus Alerts and Suggestions
Real-time alerts for Oncorus allow investors to track important stock developments as they happen. Reviewing ongoing notifications for Oncorus helps identify opportunities and risks before they are fully priced into the market.| Oncorus is not yet fully synchronised with the market data | |
| Oncorus has some characteristics of a very speculative penny stock | |
| Oncorus has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was -77.42 M with profit before overhead, payroll, taxes, and interest of 0. | |
| Oncorus currently holds about 100.24 M in cash with -61.69 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.86. | |
| Roughly 55.0% of the company shares are owned by institutional investors |
Oncorus Price Density Drivers
Market volatility will typically increase when uncertainty rises among traders holding long positions. The future price of Oncorus Stock depends not only on investor outlook but also on the dynamics between participants with different trading approaches. Because risk indicators may produce small false signals, reviewing multiple metrics is recommended. Oncorus' short-sentiment indicators are summarized below.
| Common Stock Shares Outstanding | 25.9 M | |
| Cash And Short Term Investments | 25.7 M |
Oncorus Fundamentals Growth
Oncorus Stock prices reflect investors' perceptions of the future prospects and financial health of Oncorus, and Oncorus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Oncorus Stock performance.
| Return On Equity | -1.25 | |||
| Return On Asset | -0.32 | |||
| Current Valuation | 25.71 M | |||
| Shares Outstanding | 26.09 M | |||
| Price To Book | 0.13 X | |||
| EBITDA | -75.42 M | |||
| Cash And Equivalents | 100.24 M | |||
| Cash Per Share | 3.86 X | |||
| Total Debt | 70.65 M | |||
| Debt To Equity | 0.72 % | |||
| Book Value Per Share | 1.19 X | |||
| Cash Flow From Operations | -61.69 M | |||
| Earnings Per Share | -5.49 X | |||
| Total Asset | 145.59 M | |||
| Retained Earnings | -272.01 M | |||